| Name | Orciprenaline |
|---|---|
| Synonyms |
1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane
5-(1-hydroxy-2-propan-2-ylamino-ethyl)benzene-1,3-diol 5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol 1,3-Benzenediol, -hydroxy-2-(1-methylethyl)aminoethyl 5-[1-hydroxy-2-(1-methylethylamino)ethyl]benzene-1,3-diol OrciprenalineQ: What is Orciprenaline Q: What is the CAS Number of Orciprenaline Q: What is the storage condition of Orciprenaline Q: What e the applications of Orciprenaline 5-[2-(Isopropylamino)-1-hydroxyethyl]-1,3-benzenediol Isoprenaline Hydrochloride Impurity 28 Metaproterenol 1-(3,5-dihydroxyphenyl)-2-isopropylaminoethanol 5-[1-Hydroxy-2-(isopropylamino)ethyl]-1,3-benzenediol 5-[1-Hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol Orciprenaline //BP 3,5-dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol Orciprenaline & Orciprenaline Sulfate 3,5-Dihydroxy-a-[(isopropylamino)methyl]benzyl alcohol Benzyl alcohol, 3,5-dihydroxy-a-[(isopropylamino)methyl]- (6CI, 8CI) 5-[1-hydroxy-2-(isopropylamino)ethyl]resorcinol 5-[1-Hydroxy-2-[(1-methylethyl)amino]ethyl]-1,3-benzenediol 1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]- (9CI) 1-(3,5-Dihydroxyphenyl)-2-isopropylaminoethanol 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-3-benzenediol Metaproterenol (base and/or unspecified salts) 3,5-Dihydroxy-a-[(isopropylamino)methyl]benzyl Alcohol EINECS 209-569-1 inhrine Impurity 43 3,5-dihydroxy-alpha-((isopropylamino)methyl)-benzyl alcohol 3,5-Dihydroxy-α-[(isopropylamino)methyl]benzyl alcohol |
| Description | Metaproterenol (Orciprenaline) is a direct-acting sympathomimetic and a β2-adrenergic receptor (β2AR) agonist with an IC50 of 68 nM. Metaproterenol also has anti-inflammatory activity[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 68 nM (β2-adrenergic receptor)[1] |
| In Vitro | Metaproterenol (10 μM; 74 hours; THP-1 cells and bone marrow macrophages) treatment enhances β-arrestin2 and its interaction with IκBα in high glucose-induced THP-1 cells and bone marrow macrophages[1]. Metaproterenol (10 μM; 74 hours; THP-1 cells and bone marrow macrophages) treatment leads to downregulation of NF-κB in high glucose-induced THP-1 cells and bone marrow macrophages[1]. Western Blot Analysis[1] Cell Line: THP-1 cells and bone marrow macrophages Concentration: 10 μM Incubation Time: 74 hours Result: Enhanced β-arrestin2 and its interaction with IκBα. RT-PCR[1] Cell Line: THP-1 cells and bone marrow macrophages Concentration: 10 μM Incubation Time: 74 hours Result: Led to downregulation of NF-κB. |
| In Vivo | Treatment of Zucker diabetic fatty rats with Metaproterenol for 12 weeks attenuates monocyte activation as well as pro-inflammatory and pro-fibrotic responses in the kidneys and heart. Thus, Metaproterenol might has protective effects against diabetic renal and cardiovascular complications[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 417.5±40.0 °C at 760 mmHg |
| Molecular Formula | C11H17NO3 |
| Molecular Weight | 211.258 |
| Flash Point | 179.7±17.9 °C |
| Exact Mass | 211.120850 |
| PSA | 72.72000 |
| LogP | 0.13 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.579 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|